Hepatitis B virus surface antigen impairs myeloid dendritic cell function: a possible immune escape mechanism of hepatitis B virus

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Immunology

• Publication date

  2009-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1365-2567.2008.02896.xPMID 18624732PMCID PMC2632689
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Uric acid enhances T cell immune responses to hepatitis B surface antigen-pulsed-dendritic cells in mice.

  2007cited by this paper
• Peripheral blood dendritic cells are phenotypically and functionally intact in chronic hepatitis B virus (HBV) infection

  2007cited by this paper
• Favorable effect of adefovir on the number and functionality of myeloid dendritic cells of patients with chronic HBV

  2006cited by this paper
• Dendritic cells take up viral antigens but do not support the early steps of hepatitis B virus infection

  2006cited by this paper
• Decreased numbers and impaired function of circulating dendritic cell subsets in patients with chronic hepatitis B infection (R2)

  2005cited by this paper
• Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection

  2005cited by this paper
• Immune Tolerance Split between Hepatitis B Virus Precore and Core Proteins

  2005cited by this paper
• Functional impairment of myeloid and plasmacytoid dendritic cells of pat ients with chronic hepatitis B

  2005cited by this paper
• Phenotype and function of monocyte derived dendritic cells in chronic hepatitis B virus infection.

  2004cited by this paper
• Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B

  2004cited by this paper
• Longitudinal Analysis of CD8+ T Cells Specific for Structural and Nonstructural Hepatitis B Virus Proteins in Patients with Chronic Hepatitis B: Implications for Immunotherapy

  2004cited by this paper
• CONCISE REVIEW IN MECHANISMS OF DISEASE Exploring the Biological Basis of Hepatitis B e Antigen in Hepatitis B Virus Infection

  2003cited by this paper
• Classifying Hepatitis B Virus Genotypes

  2003cited by this paper
• HBsAg/HLA-A2 transgenic mice: a model for T cell tolerance to hepatitis B surface antigen in chronic hepatitis B virus infection.

  2003cited by this paper
• Impaired function of antigen-presenting dendritic cells in patients with chronic hepatitis B: localization of HBV DNA and HBV RNA in blood DC by in situ hybridization.

  2003cited by this paper
• YSDD: a novel mutation in HBV DNA polymerase confers clinical resistance to lamivudine

  2003cited by this paper
• Hepatitis B virus‐induced defect of monocyte‐derived dendritic cells leads to impaired T helper type 1 response in vitro: mechanisms for viral immune escape

  2003cited by this paper
• Immunogenetics of the response to HBsAg vaccination.

  2003cited by this paper
• Tolerogenic dendritic cells.

  2003cited by this paper
• Recombinant HBsAg, an apoptotic-like lipoprotein, interferes with the LPS-induced activation of ERK-1/2 and JNK-1/2 in monocytes.

  2002cited by this paper
• Supporting Online Material

  2002cited by this paper
• Reduction in the circulating pDC1/pDC2 ratio and impaired function of ex vivo-generated DC1 in chronic hepatitis B infection.

  2002cited by this paper
• Hepatitis B virus surface antigen suppresses the activation of monocytes through interaction with a serum protein and a monocyte-specific receptor.

  2002cited by this paper
• Escaping High Viral Load Exhaustion

  2002cited by this paper
• Activation and maturation of antigen-presenting dendritic cells during vaccine therapy in patients with chronic hepatitis due to hepatitis B virus.

  2002cited by this paper
• Natural killer cells and dendritic cells: rendezvous in abused tissues

  2002cited by this paper
• Escaping High Viral Load Exhaustion: CD8 Cells with Altered Tetramer Binding in Chronic Hepatitis B Virus Infection

  2002cited by this paper
• Antigen decoding by T lymphocytes: from synapses to fate determination

  2001cited by this paper
• The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection.

  2000cited by this paper
• The Role of Virus-Specific Cd8+ Cells in Liver Damage and Viral Control during Persistent Hepatitis B Virus Infection

  2000cited by this paper
• Hepatitis B Virus Biology

  2000cited by this paper
• Incubation phase of acute hepatitis B in man: Dynamic of cellular immune mechanisms

  2000cited by this paper
• Localization of a unique hepatitis B virus epitope sheds new light on the structure of hepatitis B virus surface antigen.

  1999cited by this paper
• Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection.

  1999cited by this paper
• Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice.

  1998cited by this paper
• Hepatitis B virus infection.

  1998cited by this paper
• Dendritic cells and the control of immunity

  1998cited by this paper
• Hepatitis B virus infection.

  1997cited by this paper
• Induction of T‐helper cell response to hepatitis B core antigen in chronic hepatitis B: A major factor in activation of the host immune response to the hepatitis B virus

  1995cited by this paper
• Hepatitis B virus.

  1991cited by this paper
• Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA.

  1987cited by this paper
• Point mutation in the S gene of hepatitis B virus for a d/y or w/r subtypic change in two blood donors carrying a surface antigen of compound subtype adyr or adwr

  1987cited by this paper
• Expression of cloned hepatitis B virus DNA in human cell cultures.

  1980cited by this paper
• B Virus Infection

  1966cited by this paper
• HBsAg / HLA-A 2 transgenic mice : a model for T cell tolerance to hepatitis B surface antigen in chronic hepatitis B virus infection

  year unknowncited by this paper

• Discovery and Characterization of GLPG3808, a PAPD5/7 Inhibitor for Suppression of Hepatitis B Viral Infections.

  2026cites this paper
• HBsAg Suppression by a New Series of HBV RNA Destabilizers: Discovery and Effects on In Vitro Neurite Outgrowth.

  2026cites this paper
• Pre-Treatment HBV Activation Modulates Circulating Immune Markers in Hepatocellular Carcinoma Patients Undergoing TACE Plus ICIs and Anti-VEGF Antibodies/TKIs.

  2026cites this paper
• A review of the progress and challenges of developing dendritic-based vaccines against hepatitis B virus (HBV).

  2025cites this paper
• Hepatitis B virus surface antigen drives T cell immunity through non-canonical antigen presentation in mice

  2025cites this paper
• Bepirovirsen for the treatment of chronic hepatitis B infection

  2025cites this paper
• Hepatitis B surface antigen: carcinogenesis mechanisms and clinical implications in hepatocellular carcinoma

  2025cites this paper
• Ubiquitin-dependent proteasomal degradation of small hepatitis B virus surface antigen mediated by TRIM21 and antagonized by OTUD4

  2025cites this paper
• HBV and HBsAg strongly reshape the phenotype, function, and metabolism of DCs according to patients’ clinical stage

  2025cites this paper
• Innate immune recognition in hepatitis B virus infection

  2025cites this paper
• The Landscape of Anti-HBV Activity in Essential Oils: A Machine Learning-Based Virtual Screening Framework and Anti-HBV Activity of Acorus tatarinowii Schott

  2025cites this paper
• The significance of antibody to hepatitis B surface antigen in infection and clearance of hepatitis B virus

  2025cites this paper
• Chronic hepatitis B virus persistence: Mechanisms, consequences and implications for achieving cure.

  2025cites this paper
• Preclinical Antiviral and Safety Profiling of the HBV RNA Destabilizer AB-161

  2024cites this paper
• The immune response in chronic HBV infection

  2024cites this paper
• Hepatitis B surface antigen impairs TLR4 signaling by upregulating A20 expression in monocytes

  2024cites this paper
• A predictive model for functional cure in chronic HBV patients treated with pegylated interferon alpha: a comparative study of multiple algorithms based on clinical data

  2024cites this paper
• The efficacy and safety of addition of pegylated interferon to long-term nucleos(t)ide analogue therapy on functional cure of chronic hepatitis B patient: a systematic review and meta-analysis

  2024cites this paper
• Monocyte and Macrophage Functions in Oncogenic Viral Infections

  2024cites this paper
• Structure-Activity Relationships and Discovery of (S)-6-Isopropyl-2-methoxy-3-(3-methoxypropoxy)-10-oxo-5,10-dihydro-6H-pyrido[1,2-h][1,7]naphthyridine-9-carboxylic Acid (AB-452), a Novel Orally Available HBV RNA Destabilizer.

  2024cites this paper
• The role of Traditional Chinese medicine in anti-HBV: background, progress, and challenges

  2023cites this paper
• Laponite Lights Calcium Flickers by Reprogramming Lysosomes to Steer DC Migration for An Effective Antiviral CD8+ T‐Cell Response

  2023cites this paper
• Interspecies comparison of the early transcriptomic changes associated with hepatitis B virus exposure in human and macaque immune cell populations

  2023cites this paper
• Network pharmacology and experimental validation to reveal the anti-hepatitis B virus pharmacological mechanism of Phyllanthus urinaria L.

  2023cites this paper
• HBV Infection and Host Interactions: The Role in Viral Persistence and Oncogenesis

  2023cites this paper
• Phylogenetic Analysis and Emerging Drug Resistance against Different Nucleoside Analogues in Hepatitis B Virus Positive Patients

  2023cites this paper
• Function and autophagy of monocyte-derived dendritic cells is affected by hepatitis B virus infection

  2023cites this paper
• miR-146a Maintains Immune Tolerance of Kupffer Cells and Facilitates Hepatitis B Virus Persistence in Mice

  2022cites this paper
• Hepatitis B functional cure and immune response

  2022cites this paper
• Targeting TLR9 agonists to secondary lymphoid organs induces potent immune responses against HBV infection

  2022cites this paper
• Innate and adaptive immune escape mechanisms of hepatitis B virus

  2022cites this paper
• Toll-Like Receptor 7 Agonist RG7854 Mediates Therapeutic Efficacy and Seroconversion in Woodchucks With Chronic Hepatitis B

  2022cites this paper
• Innate Immunity, Inflammation, and Intervention in HBV Infection

  2022cites this paper
• Immune Mechanisms Underlying Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B Patients With Viral Coinfection

  2022cites this paper
• Engineered anti-PDL1 with IFNα targets both immunoinhibitory and activating signals in the liver to break HBV immune tolerance

  2022cites this paper
• Treatment with the Immunomodulator AIC649 in Combination with Entecavir Produces Antiviral Efficacy in the Woodchuck Model of Chronic Hepatitis B

  2021cites this paper
• The Mechanism of Interleukin-35 in Chronic Hepatitis B

  2021cites this paper
• Innate immunity in hepatitis B and D virus infection: consequences for viral persistence, inflammation, and T cell recognition

  2021cites this paper
• The impact of hepatitis B surface antigen on natural killer cells in patients with chronic hepatitis B virus infection

  2021cites this paper
• Risks and Benefits of Discontinuation of Nucleos(t)ide Analogue Treatment: A Treatment Concept for Patients With HBeAg‐Negative Chronic Hepatitis B

  2021cites this paper
• SIGLEC-3 (CD33) serves as an immune checkpoint receptor for HBV infection.

  2021cites this paper
• Modeling reveals no direct role of the extent of HBV DNA integrations on the outcome of infection.

  2021cites this paper
• Human Hepatitis B Virus Negatively Impacts the Protective Immune Crosstalk Between Natural Killer and Dendritic Cells

  2021cites this paper
• HBsAg Dampened STING Associated Activation of NK Cells in HBeAg-Negative CHB Patients

  2021cites this paper
• The Functions of Hepatitis B Virus Encoding Proteins: Viral Persistence and Liver Pathogenesis

  2021cites this paper
• Hepatitis B Surface Antigen Suppresses the Activation of Nuclear Factor Kappa B Pathway via Interaction With the TAK1-TAB2 Complex

  2021cites this paper
• Combination Therapy

  2021cites this paper
• The Role of Dendritic Cells During Infections Caused by Highly Prevalent Viruses

  2020cites this paper
• HBVsvp-Pulsed Dendritic Cell Immunotherapy Induces Th1 Polarization and Hepatitis B Virus-Specific Cytotoxic T Lymphocytes Production

  2020cites this paper
• Conference proceedings from the 22nd Bangkok International Symposium on HIV Medicine

  2020cites this paper
• Computational Design of a Novel VLP-Based Vaccine for Hepatitis B Virus

  2020cites this paper
• The potential role of HLA-G in the pathogenesis of HBV infection: Immunosuppressive or immunoprotective?

  2020cites this paper
• Mechanisms of HBV immune evasion.

  2020cites this paper
• Hepatitis B Surface Antigen Seroclearance: Immune Mechanisms, Clinical Impact, Importance for Drug Development.

  2020cites this paper
• The Effects of Nucleoside/Nucleotide Analogues on Host Immune Cells: The Baseline for Future Immune Therapy for HBV?

  2020cites this paper
• Dynamics of Hepatitis B Virus Surface Antigen Level with Peripheral Blood Lymphocytes in Chronic Hepatitis B Infection

  2020cites this paper
• The Multiple Functions of B Cells in Chronic HBV Infection

  2020cites this paper
• Efficacy of an Inhibitor of Hepatitis B Virus Expression in Combination With Entecavir and Interferon‐α in Woodchucks Chronically Infected With Woodchuck Hepatitis Virus

  2020cites this paper
• Hepatitis B Virus

  2020cites this paper
• HBsAg, Subviral Particles, and Their Clearance in Establishing a Functional Cure of Chronic Hepatitis B Virus Infection.

  2020cites this paper
• Hepatitis B virus exploits C‐type lectin receptors to hijack cDC1s, cDC2s and pDCs

  2020cites this paper
• Quantitative HBsAg titers in relation to disease progression and serum markers of iron metabolism among chronic hepatitis B patients

  2020cites this paper
• B cell dysfunction in chronic hepatitis B virus infection

  2020cites this paper
• Distinct Cytokine Profiles Correlate with Disease Severity and Outcome in Longitudinal Studies of Acute Hepatitis B Virus and Hepatitis D Virus Infection in Chimpanzees

  2020cites this paper
• Combination therapy against human infections caused by viruses

  2020cites this paper
• Therapeutic strategies for hepatitis B virus infection: towards a cure

  2019cites this paper
• Immune suppression in chronic hepatitis B infection associated liver disease: A review

  2019cites this paper
• CD4+ T cell exhaustion revealed by high PD-1 and LAG-3 expression and the loss of helper T cell function in chronic hepatitis B

  2019cites this paper
• Toward a Functional Cure for Hepatitis B: The Rationale and Challenges for Therapeutic Targeting of the B Cell Immune Response

  2019cites this paper
• Circulating and Hepatic BDCA1+, BDCA2+, and BDCA3+ Dendritic Cells Are Differentially Subverted in Patients With Chronic HBV Infection

  2019cites this paper
• Roadmap to functional cure of chronic hepatitis B: An expert consensus

  2019cites this paper
• Плазмоцитоидные дендритные клетки и их роль в иммунопатогенезе вирусных инфекций на примере гепатита В

  2019cites this paper
• PAPD5/7 Are Host Factors That Are Required for Hepatitis B Virus RNA Stabilization

  2019cites this paper
• Liver DCs in health and disease.

  2019cites this paper
• Immunological Features of AECHB

  2019cites this paper
• Hepatitis B Virus Inhibits Neutrophil Extracellular Trap Release by Modulating Reactive Oxygen Species Production and Autophagy

  2019cites this paper
• HBV coinfection with HCV alters circulating Tfh cell distribution and impairs HCV neutralizing antibody responses

  2019cites this paper
• Plasmacytoid dendritic cells and their role in the immunopathogenesis of viral infections for example hepatitis B

  2019cites this paper
• Characterization Of The Interaction Between Subviral Particles Of Hepatitis B Virus And Dendritic Cells – In Vitro Study

  2019cites this paper
• The Management of Glucocorticoid Therapy in Liver Failure

  2019cites this paper
• Plant-derived RNAi therapeutics: A strategic inhibitor of HBsAg.

  2019cites this paper
• Mechanisms of Hepatitis B Virus Persistence.

  2018cites this paper
• Strategies for immune evasion by human tumor viruses.

  2018cites this paper
• Current concepts on immunopathogenesis of hepatitis B virus infection.

  2018cites this paper
• Quantitation of Plasmacytoid Dendritic Cells in Chronic Hepatitis B Patients with HBeAg Positivity During PEG-IFN and Entecavir Therapy

  2018cites this paper
• Immunization with lentiviral vector‑modified dendritic cells encoding ubiquitinated hepatitis B core antigen promotes Th1 differentiation and antiviral immunity by enhancing p38 MAPK and JNK activation in HBV transgenic mice.

  2018cites this paper
• The Role of New Viral Biomarkers in Chronic Hepatitis B: Ready to Use in the Clinical Practice?

  2018cites this paper
• Discovery of Small Molecule Therapeutics for Treatment of Chronic HBV Infection.

  2018cites this paper
• CD56bright natural killer cells induce HBsAg reduction via cytolysis and cccDNA decay in long‐term entecavir‐treated patients switching to peginterferon alfa‐2a

  2018cites this paper
• HBx-Derived Constrained Peptides Inhibit the Secretion of Hepatitis B Virus Antigens.

  2018cites this paper
• Control of viral transcripts as a concept for future HBV therapies.

  2018cites this paper
• Unconventional T cells in chronic hepatitis B patients on long‐term suppressive therapy with tenofovir followed by a Peg‐IFN add‐on strategy: A randomized study

  2018cites this paper
• Placental expression of asialoglycoprotein receptor associated with Hepatitis B virus transmission from mother to child

  2018cites this paper
• Genome-wide profiling of microRNAs reveals novel insights into the interactions between H9N2 avian influenza virus and avian dendritic cells

  2018cites this paper
• Plasmacytoid Dendritic Cell Function and Cytokine Network Profiles in Patients with Acute or Chronic Hepatitis B Virus Infection

  2018cites this paper
• Liver-Targeted Anti-HBV Single-Stranded Oligonucleotides with Locked Nucleic Acid Potently Reduce HBV Gene Expression In Vivo

  2018cites this paper
• Association of Cytokines with Alanine Aminotransferase, Hepatitis B Virus Surface Antigen and Hepatitis B Envelope Antigen Levels in Chronic Hepatitis B

  2018cites this paper
• Discovery of RG7834: The First-in-Class Selective and Orally Available Small Molecule Hepatitis B Virus Expression Inhibitor with Novel Mechanism of Action.

  2018cites this paper
• Hepatitis B Virus Inhibits Neutrophil Extracellular Traps Release by Modulating Reactive Oxygen Species Production and Autophagy

  2018cites this paper
• Luteolin-7-O-Glucoside Present in Lettuce Extracts Inhibits Hepatitis B Surface Antigen Production and Viral Replication by Human Hepatoma Cells in Vitro

  2017cites this paper